Published December 2018
| Version v1
Journal article
The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome
Creators
- 1. Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America (United States)
- 2. Cardiovascular Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States of America (United States)
Description
Dual antiplatelet therapy (DAPT) varies after placement of drug-eluting stents (DES) in patients presenting with acute coronary syndromes (ACS). Our aim was to study patient characteristics and predictors of switching, in-hospital or at discharge, from clopidogrel (CLO) to ticagrelor (TIC) or vice versa.
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2018.09.007;
- PII
- S1553838918304081;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 19
- Journal Issue
- 8
- Journal Page Range
- p. 912-916
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55055147
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARDIOVASCULAR DISEASES; CORONARIES; DRUGS; HOSPITALS; PATIENTS; THERAPY
- Descriptors DEC
- ARTERIES; BLOOD VESSELS; BODY; BUILDINGS; CARDIOVASCULAR SYSTEM; DISEASES; MEDICAL ESTABLISHMENTS; MEDICINE; ORGANS
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.